These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway. Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657 [TBL] [Abstract][Full Text] [Related]
8. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis. Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418 [TBL] [Abstract][Full Text] [Related]
9. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581 [TBL] [Abstract][Full Text] [Related]
10. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl Liu QQ; Chen J; Ma T; Huang W; Lu CH Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618 [TBL] [Abstract][Full Text] [Related]
11. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells. Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448 [TBL] [Abstract][Full Text] [Related]
12. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Wang B; Koh P; Winbanks C; Coughlan MT; McClelland A; Watson A; Jandeleit-Dahm K; Burns WC; Thomas MC; Cooper ME; Kantharidis P Diabetes; 2011 Jan; 60(1):280-7. PubMed ID: 20952520 [TBL] [Abstract][Full Text] [Related]
13. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a. Yu F; Fan X; Chen B; Dong P; Zheng J Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition. Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268 [TBL] [Abstract][Full Text] [Related]
15. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis. Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779 [TBL] [Abstract][Full Text] [Related]
16. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Wu SM; Li TH; Yun H; Ai HW; Zhang KH Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340 [TBL] [Abstract][Full Text] [Related]
17. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Li ZJ; Ou-Yang PH; Han XP Cell Signal; 2014 Jan; 26(1):141-8. PubMed ID: 24100264 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078 [TBL] [Abstract][Full Text] [Related]
20. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis. Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]